The EUTOS score identifies chronic myeloid leukeamia patients with poor prognosis treated with imatinib first or second line

MeSH terms

• Antineoplastic Agents / therapeutic use
• Benzamides
• Chemotherapy, Adjuvant
• Diagnostic Techniques and Procedures*
• Female
• Humans
• Imatinib Mesylate
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
• Male
• Middle Aged
• Neoadjuvant Therapy
• Piperazines / therapeutic use*
• Predictive Value of Tests
• Prognosis
• Pyrimidines / therapeutic use*
• Research Design
• Retrospective Studies
• Survival Analysis
• Treatment Outcome